Nebulized salbutamol (Asmasal) in Thai children with asthma: comparison of three doses.
Asian Pac J Allergy Immunol
;
1994 Jun; 12(1): 7-13
Artículo
en Inglés
| IMSEAR
| ID: sea-36661
ABSTRACT
Eleven moderate-to-severe asthmatic children 5-11 years of age who were in stable condition were given (randomly, double-blind) nebulized salbutamol sulfate (Asmasal) inhalation therapy at doses of 0.1, 0.2 and 0.3 mg/kg body weight on separated days. All three doses of nebulized solution resulted in clinical improvement and improvement of lung function (FEV1, FVC, PEFR and FEF25-75%). A dose of 0.3 mg/kg produced greatest improvement and longest duration of improvement in FEV1 and PEFR, but the change was statistically significant only in PEFR at 60 minutes (p < 0.05). Five children experienced mild tremors. There were no significant changes in heart rate or blood pressure at any dose. It is concluded that a nebulized solution of salbutamol sulfate at a dose of 0.1-0.3 mg/kg is useful for treatment of asthma in Thai children, with very mild side effects.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Asma
/
Tailandia
/
Administración por Inhalación
/
Femenino
/
Humanos
/
Masculino
/
Niño
/
Método Doble Ciego
/
Estudios Cruzados
/
Ventilación Pulmonar
Tipo de estudio:
Ensayo Clínico Controlado
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
Asian Pac J Allergy Immunol
Año:
1994
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS